• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Siemens investors back Kaeser

Siemens investors back Kaeser

September 27, 2016 By MassDevice

Siemens(Reuters) – Siemens (NYSE:SI) Chief Executive Joe Kaeser has signaled he wants to renew his contract when it runs out in 2018, a move welcomed by investors who have grown to trust the 59-year-old company veteran.

Kaeser ousted his predecessor Peter Loescher in a boardroom coup in July 2013 when he was finance chief. Since then he has streamlined the German group to focus on its strengths in industrial engineering, raised profitability and seen the share price respond this year.

There is still work to be done but investors believe Kaeser deserves a new contract.

The trains-to-turbines group trails rivals with its enterprise value of 9.7 times estimated 2016 core profit, below multiples of 17.3 for General Electric, 10.5 for ABB and 10.4 for Schneider Electric.

But after a clean-up of underperforming businesses, almost 1 billion euros ($1.1 billion) in cost cuts and the sale of Siemens’ last consumer operations, investors see the group as well placed to take advantage of opportunities in its markets.

“We are happy with his work. The first successes of his revamp are visible. Profitability is rising and we’re not at the end yet by a long way. We see a lot of upside,” said portfolio manager Christoph Niesel of Union Investment, a top 20 investor.

Kaeser is expected to oversee a spin-off of Siemens’ healthcare unit, valued at about 20 billion euros, within the next year or two after Kaeser separated it legally and operationally from the rest of the group.

WINNING OVER CRITICS

German business daily Handelsblatt wrote on Sunday that Kaeser had signaled to Siemens’ supervisory board he would be happy to continue beyond 2018, citing company sources.

The report came two days after long-serving and respected Chief Technology Officer Siegfried Russwurm said he would not extend his contract beyond next March, by “mutual agreement” with the supervisory board.

Russwurm was regarded as a potential alternative chief executive.

A Siemens spokesman declined to comment on the Handelsblatt report and a supervisory board member said the issue had not been discussed.

Kaeser’s popularity is perhaps higher than at any time since he took over.

As recently as January’s annual meeting, shareholders were bitterly complaining about Siemens’ lagging share price, the dangers of ambitious new projects such as a deal to build energy infrastructure in Egypt, and the ill-timed acquisition of U.S. oilfield equipment Dresser-Rand — at $7.8 billion, Siemens’ biggest-ever takeover.

Since then, the share price has risen by one-sixth, outperforming the German blue-chip DAX by 8%, while the oil price has jumped by almost half, improving prospects for the Dresser-Rand business.

The Egyptian project, Siemens’ biggest-ever contract, is on track so far, unlike other large Siemens projects in the past, which often ran into problems that regularly caused hundreds of millions of euros in unexpected charges.

“Siemens executes the big projects much better than in the past,” said another top 10 Siemens shareholder, who asked not to be named because he is not authorised to speak to the media.

RUTHLESS STREAK

Kaeser — a sharp dresser who shaved off his trademark moustache upon becoming CEO and is at ease with the financial community thanks to his seven years as CFO — has also endeared himself to investors with a 3 billion-euro share buyback scheme over three years.

Operating profitability at Siemens’ industrial businesses rose to 10.8% last quarter from 6.5% before Kaeser took over, and disposals of units including hearing-aids and home appliances brought welcome gains.

At the same time, Kaeser has beefed up Siemens’ engineering simulation software with large acquisitions including CD-adapco of the United States this year, making it the only industrial automation player globally with integrated software.

Kaeser’s fortunes could change again rapidly, though: In recent media interviews he has said he is “very cautious” about geopolitical uncertainty clouding the investment climate for 2017.

Investors also point to his ruthless nature, which helped him to get the job, as a potential weakness.

“The one point where he has to be a bit careful is to make sure he has the backing of other top management. We’ve seen Russwurm and other managers leaving,” said the top 10 investor.

Others were concerned that Kaeser could be drawing his power from too narrow a base.

Union Investment’s Niesel said: “Russwurm is one of the names you’d think of when considering who would lead the company. Everything is now tailor-made for Mr Kaeser and his team. But that’s an issue for Siemens management.”

Filed Under: Business/Financial News Tagged With: Siemens

In case you missed it

  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
  • FDA says Philips ventilator recall produced over 21,000 device reports, 124 deaths
  • Boston Scientific’s Acurate Neo2 valve performs well in studies
  • MicroTransponder reports first commercial implantation of its stroke rehab neurostim system
  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D
  • Abbott reports positive data on heart valve therapies
  • OncoRes Medical raises another $12.5M
  • NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia
  • Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says

RSS From Medical Design & Outsourcing

  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS